본문 바로가기

연구소

연구논문 및 특허성과

  • Home
  • 연구소
  • 연구논문 및 특허성과

논문성과

암센터 국문 논문 목록
학술지 책임저자
제1저자
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor)
The effect of fragmented cancer care and change in nurse staffing grade on cancer patient mortality Seungju Kim
Seungju Kim:한규태:. The effect of fragmented cancer care and change in nurse staffing grade on cancer patient mortality WORLDVIEWS ON EVIDENCE-BASED NURSING. 2023-09-10; 2023; :~. IF 4.3 (2022)
한규태
(암관리정책부)
Gastroesophageal Reflux Disease and Risk of Cancer: Findings from the Korean National Health Screening Cohort 오진경
(암관리학과)
오진경:Chi Lan Tran:김병미, 김영일, Minji Han, Eun Young Park. Gastroesophageal Reflux Disease and Risk of Cancer: Findings from the Korean National Health Screening Cohort CANCER MEDICINE. 2023-09-07; 2023; :~. IF 4 (2022)
Chi Lan Tran
Nivolumab after Induction Chemotherapy in Previously Treated Non-Small-Cell Lung Cancer Patients with Low PD-L1 Expression 한지연1
(폐암센터)
한지연1:박찬이, 안병철:이상진, 홍세화, 권경숙, 김진영, 김경희, 김혜영, 이건국, 이영주, Ji-Eun Hwang. Nivolumab after Induction Chemotherapy in Previously Treated Non-Small-Cell Lung Cancer Patients with Low PD-L1 Expression CANCERS. 2023-09-07; 2023; 15(18):4460~. IF 5.2 (2022)
박찬이
(생물정보연구과)
안병철
(혈액종양내과분과)
Bidirectional connectivity alterations in schizophrenia: a multivariate, machine-learning approach Minchul Kim
Minchul Kim:서지원, Minhoe Kim:. Bidirectional connectivity alterations in schizophrenia: a multivariate, machine-learning approach FRONTIERS IN PSYCHIATRY. 2023-09-07; 2023; :~. IF 4.7 (2022)
서지원
(영상의학과)
Adherence of PARP inhibitor for frontline maintenance therapy in primary epithelial ovarian cancer: a cross-sectional survey 임명철
(자궁난소암센터)
임명철:김지현:김시내, 서상수, 강석범, 박상윤, Yumi Lee, Da-Young Kim. Adherence of PARP inhibitor for frontline maintenance therapy in primary epithelial ovarian cancer: a cross-sectional survey JOURNAL OF GYNECOLOGIC ONCOLOGY. 2023-09-05; 2023; :~. IF 3.9 (2022)
김지현
(산부인과)
Rapid Immunodot AQP4 Assay for Neuromyelitis Optica Spectrum Disorder 김호진
(희귀난치암연구부)
김호진, Wei Qiu:Ying Fu, Jin Bi, Yaping Yan, Xiaobo Sun:김소연, 한상민. Rapid Immunodot AQP4 Assay for Neuromyelitis Optica Spectrum Disorder JAMA NEUROLOGY. 2023-09-05; 2023; :~. IF 29 (2022)
Ying Fu, Jin Bi, Yaping Yan, Xiaobo Sun
Phase 1 trial of 4-1BB-based adoptive T-cell therapy targeting human telomerase reverse transcriptase in patients with advanced refractory solid tumors Byoung S. Kwon
Byoung S. Kwon:최원영, 이영주, 최범규:박보미, Young H Kim, 윤탁, 이우진, 유헌, 백지연, 우상명, 임명철. Phase 1 trial of 4-1BB-based adoptive T-cell therapy targeting human telomerase reverse transcriptase in patients with advanced refractory solid tumors CYTOTHERAPY. 2023-08-25; 2023; :~. IF 4.5 (2022)
최원영
(암분자생물학연구과)
이영주
(폐암센터)
Impact of warm saline irrigation, hyperthermic intraperitoneal chemotherapy on postoperative pain in primary ovarian cancer from the KOV-HIPEC-01 randomized trial 윤정연
(마취통증의학과)
임명철
(희귀ㆍ소아암연구과)
윤정연, 임명철:김지현:박은영, 장민정, 박상윤, Kyung Nam Park, Yoen Jung Park, Youseok Kim, Suk-Joon Chang. Impact of warm saline irrigation, hyperthermic intraperitoneal chemotherapy on postoperative pain in primary ovarian cancer from the KOV-HIPEC-01 randomized trial GYNECOLOGIC ONCOLOGY. 2023-08-25; 2023; 117:32~37. IF 4.7 (2022)
김지현
(산부인과)
Short-term effects of national smoking cessation service on smoking-related disease prevalence and healthcare costs: An experience from the National Health Insurance Service Smoking Cessation Intervention Program in Korea Min Kyung Lim
Min Kyung Lim:오진경:Minji Han. Short-term effects of national smoking cessation service on smoking-related disease prevalence and healthcare costs: An experience from the National Health Insurance Service Smoking Cessation Intervention Program in Korea TOBACCO INDUCED DISEASES. 2023-08-24; 2023; 21:107~. IF 3.7 (2022)
오진경
(암관리학과)
Combinations of lifestyle behaviors and cancer risk among Korean adults 오진경
(암관리학과)
오진경:Ngoc Minh Luu:Thi Tra Bui, Thi Phuong Thao Tran, Thi Huyen Trang Nguyen. Combinations of lifestyle behaviors and cancer risk among Korean adults SCIENTIFIC REPORTS. 2023-08-23; 2023; 13(1):13765~. IF 4.6 (2022)
Ngoc Minh Luu